Our results demonstrate the role of VWF in T‐cell homing and the pathogenesis of GVHD, and the potential therapeutic benefit of interrupting T‐cell migration by administrating ADAMTS13 or recombinant VWF‐A2 peptide. The gene discussed is VWF; the disease is graft versus host disease.